The mRNA Vaccine promises to reduce the Risk of Melanoma Relapse
You would know Messenger RNA (mRNA) vaccines played a crucial role in helping us overcome the pandemic blues. Although mRNA vaccines were originally aimed against cancer, their effectiveness against infectious diseases brought the vaccines to the headlines during the pandemic. However, recent research has shown that the significance of the vaccine is not limited to COVID only. It suggests that some specially curated mRNA shots can help in the prevention of melanoma (a dreaded skin cancer) relapse. Excerpts from the Study The study was published on Sunday at a research conference. It showed that after two years of receiving a personalized mRNA vaccine made by Moderna and Merck, patients were 44% more likely to be alive, and reduced the chances of new tumors. A longer study is planned to start later this year. If the results stay constant, it would be a crucial transformation in cancer vaccines that have been tested for decades. Dr. Ryan Sullivan (Oncologist at Mass Ge...